Time course of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients presenting with acute coronary syndrome

被引：2

作者：

Bertsch, T

Sueselbeck, T

Wolpert, C

Hoffmann, U

Kaden, JJ

Haase, KK

Borggrefe, M

Brueckmann, M

机构：

[1] Clin Nuremberg, Inst Clin Chem & Lab Med, D-90419 Nurnberg, Germany

[2] Univ Heidelberg, Fac Clin Med Mannheim, Dept Med 1, D-6800 Mannheim, Germany

来源：

CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2005年 / 43卷 / 06期

关键词：

acute coronary syndrome; matrix metalloproteinase-9; tissue inhibitor of matrix metalloproteinase-1;

D O I：

10.1515/CCLM.2005.113

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：660 / 663

页数：4

共 13 条

[1] Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes [J].

Brueckmann, M ;

Bertsch, T ;

Lang, S ;

Sueselbeck, T ;

Wolpert, C ;

Kaden, JJ ;

Jaramillo, C ;

Huhle, G ;

Borggrefe, M ;

Haase, KK .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (10) :1132-1139

[2] Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs [J].

Etoh, T ;

Joffs, C ;

Deschamps, AM ;

Davis, J ;

Dowdy, K ;

Hendrick, J ;

Baicu, S ;

Mukherjee, R ;

Manhaini, M ;

Spinale, FG .

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (03) :H987-H994

[3] A ONE-STEP SANDWICH ENZYME-IMMUNOASSAY FOR INACTIVE PRECURSOR AND COMPLEXED FORMS OF HUMAN MATRIX METALLOPROTEINASE-9 (92-KDA GELATINASE TYPE-IV COLLAGENASE, GELATINASE-B) USING MONOCLONAL-ANTIBODIES [J].

FUJIMOTO, N ;

HOSOKAWA, N ;

IWATA, K ;

SHINYA, T ;

OKADA, Y ;

HAYAKAWA, T .

CLINICA CHIMICA ACTA, 1994, 231 (01) :79-88

[4] INCREASED EXPRESSION OF MATRIX METALLOPROTEINASES AND MATRIX-DEGRADING ACTIVITY IN VULNERABLE REGIONS OF HUMAN ATHEROSCLEROTIC PLAQUES [J].

GALIS, ZS ;

SUKHOVA, GK ;

LARK, MW ;

LIBBY, P .

JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2493-2503

[5] Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in pa with acute coronary syndrome [J].

Inokubo, Y ;

Hanada, H ;

Ishizaka, H ;

Fukushi, T ;

Kamada, T ;

Okumura, K .

AMERICAN HEART JOURNAL, 2001, 141 (02) :211-217

[6] Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes [J].

Kai, HK ;

Ikeda, H ;

Yasukawa, H ;

Kai, M ;

Seki, Y ;

Kuwahara, F ;

Ueno, T ;

Sugi, K ;

Imaizumi, T .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (02) :368-372

[7] Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas [J].

Kossakowska, AE ;

Edwards, DR ;

Prusinkiewicz, C ;

Zhang, MC ;

Guo, DL ;

Urbanski, SJ ;

Grogan, T ;

Marquez, LA ;

Janowska-Wieczorek, A .

BLOOD, 1999, 94 (06) :2080-2089

[8]

Nomoto Kazumiki, 2003, J Cardiol, V42, P201

[9] Potential role of angiotensin converting enzyme inhibitors in the treatment of atherosclerosis [J].

Pitt, B .

EUROPEAN HEART JOURNAL, 1995, 16 :49-54

[10] INTERLEUKIN-6 ENHANCES THE PRODUCTION OF TISSUE INHIBITOR OF METALLOPROTEINASES (TIMP) BUT NOT THAT OF MATRIX METALLOPROTEINASES BY HUMAN FIBROBLASTS [J].

SATO, T ;

ITO, A ;

MORI, Y .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 170 (02) :824-829

← 1 2 →